Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides for Fatty Liver: Research Compound Comparison

BPC-157 Anti-inflammatory, angiogenic NF-κB inhibition, VEGF upregulation 60% reduction in serum ALT, 40% reduction in steatosis score (Journal of Physiology Paris) Lyophilized at -20°C; reconstituted at 2–8°C, use within 14 days Most versatile hepatoprotectiv

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • BPC-157
  • Anti-inflammatory, angiogenic
  • NF-κB inhibition, VEGF upregulation
  • 60% reduction in serum ALT, 40% reduction in steatosis score (Journal of Physiology Paris)
  • Lyophilized at -20°C; reconstituted at 2–8°C, use within 14 days
  • Most versatile hepatoprotective peptide. Addresses inflammation and tissue repair simultaneously
  • Thymosin Beta-4
  • Anti-fibrotic, stellate cell inhibition
  • TGF-β blockade, actin sequestration
  • 55% reduction in hepatic collagen deposition (Hepatology)
  • Lyophilized at -20°C; reconstituted at 2–8°C, protected from light
  • Critical for preventing fibrosis progression. The irreversible stage of NAFLD
  • AOD-9604
  • Lipolytic, lipid oxidation
  • Hormone-sensitive lipase activation, PPAR-α signaling
  • 30% increase in hepatic fatty acid oxidation (Obesity Research)
  • Lyophilized at -20°C; reconstituted at 2–8°C, use within 28 days
  • Selectively targets hepatic lipid burden without systemic glucose effects